No Data
Market cap soared nearly 40 billion Hong Kong dollars! Has Akeso really defeated the global "Drug King"?
Akeso's stock price has risen by 270% in the past three months. Why is the market so enthusiastic? Institutional investors have significantly raised the target price for the company. How do we see the market outlook in the future?
The Fed has started an interest rate cut cycle, with funds flowing into Chinese assets! Which Hong Kong stocks have taken the lead?
With the stimulus of the upcoming interest rate cut by the Federal Reserve, Chinese assets have shown signs of a breakout in recent times. The Hang Seng Tech Index has risen for five consecutive trading days, and several high-performing stocks have also started the market trend this month.
Hong Kong stocks closed (09.16) | The Hang Seng Index rose 0.31%, and shares of innovative drug concept stocks led the gains. Yimingang Corporation (01541) doubled in value in three days.
Affected by multiple bearish news over the weekend, the Hong Kong stock market opened lower in the morning, but then maintained a volatile rise throughout the day. As of the close, the Hang Seng Index rose by 0.31% or 53.03 points, to 17422.12 points.
Hong Kong stock market abnormal | Akeso (09926) surged over 17% to a record high, with a cumulative increase of over 45% this month. Morgan Stanley stated that the data for ivosidenib (HARMONi-2) far exceeded expectations.
Akeso (09926) has expanded its intraday gain by more than 17% and reached a high of HK$72.55, a new historical high. The stock has accumulated a monthly gain of over 45%. As of the time of writing, it is up 16.06%, at HK$71.5, with a trading volume of HK$0.904 billion.
Akeso's Ivonescimab Plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
Credit Suisse: Maintains a "shareholding" rating for Akeso (09926), with the target price raised to HK$78.
Morgan Stanley has released a research report stating that it maintains a 'shareholding' rating for Akeso (09926) and has raised the target price from HKD 64 to HKD 78.
No Data
No Data